CHO Prime® Media & Feeds for CHO cell culture

  • CHO Prime® Media & Feeds for CHO cell culture 1
  • CHO Prime® Media & Feeds for CHO cell culture 2
Product Description

CHO Prime® is a next-generation, GMP-compliant, adaptive media platform designed to maximise productivity while giving you precise control over critical quality attributes, particularly glycosylation. Built for production of biologics and biosimilars, CHO Prime® combines chemically defined, animal component free formulations with intelligent media design to deliver performance without compromise. 

Read more Show less

UGA Biopharma GmbH

  • Country/Region:
    Germany
  • Founded:
    2009
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile
Categories
more categories Show less
Specifications
  • Details
    CHO Prime® Products are chemically defined and protein-free, free from animal- and human-derived components (ADCF), manufactured under GMP -compliant conditions, and optimised for high-producing cell lines reaching elevated peak cell densities. CHO Prime® LG Medium w.o. HT is specifically developed to reduce galactosylated N-glycan species during manufacturing. It enables closer alignment with originator glycan profiles, a critical success factor in biosimilar development. CHO Prime® and CHO Prime® LG can be used as stand-alone media or blended to precisely finetune glycosylation levels.
  • Selling Points
    Brand Name; International Approvals/Standards; Price; Product Performance; Quality Service; Reputation; Small Orders Accepted
  • Supplied from
    Germany
  • Measured In
    litre
More specifications Fewer specifications
Sales Markets
Show more Show less

UGA Biopharma GmbH

  • Country/Region:
    Germany
  • Founded:
    2009
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile

More Products from UGA Biopharma GmbH (2)

  • Ready-to Use CHO cell lines

    Product Ready-to Use CHO cell lines

    UGA Biopharma GmbH offers to their clients Ready-to-use Biosimilar Cell Lines. These are in-house developed CHO cell lines stably expressing different blockbuster biosimilar molecules, that are instantly available for in-licensing. The client profits of direct availability of cell lines banks and prompt ac...
  • Cell Line Development services

    Product Cell Line Development services

    Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, upstream bioprocess optimization, Down stream bioprocessing and analytical characterization of the target molecule. In addition to a detailed documentation in line with regulatory requirement...